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Self-assembled artificial viral capsid bearing coiled-coils at the 
surface 
Seiya Fujita and Kazunori Matsuura*  
In order to construct artificial viral capsids bearing complementary dimeric coiled-coils on the surface, β-annulus peptide 
bearing a coiled-coil forming sequence at the C-terminus (β-annulus-coiled-coil-B) was synthesized by a native chemical 
ligation of β-annulus-SBn peptide with Cys-containing coiled-coil-B peptide. Dynamic light scattering (DLS) measurements 
and transmission electron microscope (TEM) images revealed that the β-annulus-coiled-coil-B peptide self-assembled into 
spherical structures of about 50 nm in 10 mM Tris-HCl buffer. Circular dichroism (CD) spectra indicated formation of the 
complementary coiled-coil structure on the spherical assemblies. Addition of 0.25 equivalent of complementary coiled-
coil-A peptide to the β-annulus-coiled-coil-B peptide showed the formation of spherical assemblies of 46 ± 14 nm with 
grains of 5 nm at the surface, whereas addition of 1 equivalent of complementary coiled-coil-A peptide generated fibrous 
assemblies.  
Introduction 
Supramolecules constructed by self-assembly of rationally designed 
peptides and proteins have attracted much attention because of their 
potential to achieve non-natural functions. Rationally designed 
coiled-coil α-helices and β-sheets, which are typical structural 
motifs of proteins, have been employed as building blocks of various 
artificial supramolecules.1 Coiled-coil is formed from two or more 
α-helices due to hydrophobic interactions and electrostatic 
interactions, of which the aggregation number can be regulated by 
replacement of hydrophobic amino acids.2 To date, coiled-coil 
assemblies possessing various morphologies such as fibers,3 tubes,4 
polyhedrons,5 capsules,6 and fractal structure7 have been constructed 
from designed coiled-coil peptides.8 Virus-like aggregates have also 
been constructed from coiled-coil motif. For example, Robinson et 
al. developed an antigen-displaying vesicle based on coiled-coil 
formation.9 Ryadnov et al. reported virus-like aggregates consisting 
of RNA encapsulated in spherical coiled-coil assembly.10 
Viruses are natural supramolecular assemblies with discrete size, 
consisting of genomic nucleic acids encapsulated in an outer protein 
shell known as capsid protein. Most spherical viral capsids are self-
assembled from multiples of 60 proteins, which have regular 
icosahedral symmetry.11 Recently, the discrete nanospace of viral 
capsids has attracted much attention as a nanocarrier and 
nanoreactor.12 For example, Douglas et al. reported synthesis of iron 
oxide nanoparticles in the interior of cowpea chlorotic mottle virus 
(CCMV).13 Cornelissen et al. encapsulated horse radish peroxidase 
and green fluorescence protein (GFP) into the recombinant CCMV 
capsid.14 The regular surface of viral capsids is also useful as a 
scaffold for the display of functional molecules such as 
carbohydrates,15 proteins,16 DNA,17 quantum dots18, and gold 
nanoparticles.19 
Some natural viruses such as adenovirus and influenza virus 
have protein spikes on the surface. It is known that the spikes 
on the viral capsid increase cell-surface recognition and 
infectivity owing to the increased surface area. For example, 
influenza virus has trimer coiled-coil spikes known as 
hemagglutinin, of which three binding sites at the top recognize 
α2,3- or α2,6-sialyl lactose moiety of gangliosides on the host 
cell surface at infection.20 Adenovirus has spikes of triple β-
spiral structure with each penton base of the capsid that attach 
to the host cell via the receptor on the host cell surface.21 
Recently, Yamashita et al. constructed an artificial ball-and-
spike protein supramolecule through the self-assembly of a 
fusion protein consisting of Dps protein from the bacterium 
Listeria innocua (LisDps) and cell punctuating needles (gp5C) 
of the T4 bacteriophage.22  
We have developed an artificial viral capsid self-assembled 
from a 24-mer β-annulus peptide fragment (INHVGGTGGAIM 
APVAVTRQLVGS) which participates in the formation of the 
dodecahedral internal skeleton of tomato bushy stunt virus.23 
The pH dependence of the ζ-potentials of artificial viral capsid 
indicates that the C-terminus is directed to the surface, whereas 
the N-terminus is directed to the interior.24 The artificial viral 
capsid can encapsulate anionic dyes, DNA,24 and CdTe 
quantum dots25 in the cationic interior. Using the N-terminus 
modification, His-tagged GFP26 and fluorescent ZnO 
nanoparticles27 were also encapsulated into the artificial viral 
capsid. The C-terminus modification allowed decoration of the 
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artificial viral capsid surface with gold nanoparticles28 and 
DNA29. 
In this study, we describe the creation of an artificial viral 
capsid bearing coiled-coil structures on the surface, mimicking 
natural viruses bearing spikes (Figure 1). The hetero-dimeric 
coiled-coil forming sequence was designed using the methods 
described in Woolfson.6 β-Annulus peptide bearing the coiled-
coil forming sequence at the C-terminus was synthesized by 
native chemical ligation (NCL). Addition of complementary 
coiled-coil-A peptide to the artificial viral capsid self-
assembled from β-annulus-coiled-coil-B peptide generated 
capsids with coiled-coil spikes on the surface.  
Results and discussion 
In general, it is difficult to synthesize peptides comprising 
approximately 50 residues, in high yield, using standard solid 
phase peptide synthesis (SPPS). Therefore, we synthesized the 
49-mer β-annulus-coiled-coil-B peptide by the native chemical 
ligation (NCL) method,30 in which peptides bearing unprotected 
cysteine residues at the N-terminus are ligated with C-terminus 
thioesterified peptide at neutral pH via S-N acyl shift. Dawson 
developed NCL using peptides activated with an N-
acylbenzimidazolinone (Nbz) group at the C-terminus that can 
be synthesized by Fmoc-SPPS.31 Recently, peptide syntheses 
by Dawson’s NCL method have been reported32 due to its 
advantages such as generation of activated peptide-esters by 
Fmoc solid phase synthesis without isolation of the protected 
peptide, and the ability to thioesterify the obtained peptide-Nbz 
in ligation buffer. Therefore, we synthesized β-annulus-coiled-
coil-B peptide by NCL using the β-annulus-Nbz peptide, which 
can be synthesized with Fmoc-SPPS. Figure 2 shows the 
synthetic scheme of the β-annulus-coiled-coil-B peptide. β-
Annulus-Nbz peptide (INHVGGTGGAIMAPVAVTRQLVGG-
Figure 2. Synthesis of β-annulus-coiled-coil-B peptide by native 
chemical ligation.
 
Figure 1. Schematic illustration of construction of artificial viral capsid bearing coiled-coils on the surface. 
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Nbz) was synthesized at 0.25 mmol scale on commercially 
available Dawson Dbz AM resin. The amino group of the resin 
was protected by allyloxycarbonate (Alloc) to prevent 
branching before loading the first amino acid.33 After loading 
the amino acid, the Alloc group was deprotected with PhSiH3 
and Pd(PPh3)4 and the resin was treated with p-
nitrophenylchloroformate to convert the Nbz group. β-Annulus-
Nbz peptide was deprotected and cleaved from the resin by 
treatment with a cleavage cocktail trifluoroacetic acid 
(TFA):water:1,2-ethanedithiol:triisopropylsilane = 
9.5:0.25:0.25:0.1. Coiled-coil-A peptide 
(EIAALEKENAALEQEIAALEQ) and coiled-coil-B peptide 
(CGGGKIAALKKKNAALKQKIAALK 
Q) were synthesized on Fmoc-NH-SAL resin using Fmoc-
based coupling reactions. The coiled-coil-B peptide has a GGG 
linker between the Cys and coiled-coil forming sequence to 
reduce steric hindrance in the NCL reaction and coiled-coil 
formation on the artificial viral capsid. All peptides were 
purified by reverse phase-HPLC and confirmed by MALDI-
TOF-MS.  
Although Dawson reported that NCL proceeded by mixing 
peptide-Nbz and the Cys-containing peptide,34 the NCL 
reaction between the β-annulus-Nbz peptide and coiled-coil-B 
peptide minimally proceeded because the hydrolysis of β-
annulus-Nbz peptide occurred faster than thioesterification of 
the peptide at C-terminus by 4-mercaptobenzoic acid (MPAA). 
To avoid hydrolysis of the β-annulus-Nbz peptide,35 we tried 
Figure 3. (A) Reverse-phase HPLC chromatograms of (a) 
mixture of β-annulus-SBn peptide and coiled-coil-B peptide, (b) 
NCL mixture (6M Gdn•HCl, 20 mM TCEP, 200 mM MPAA, 200 
mM sodium phosphate, 1 mM  β-annulus-SBn peptide , 1.5 
mM  coiled-coil-B peptide) reacted for 1h (B) MALDI-TOF-MS of 
the purified β-annulus-coiled-coil-B peptide.  
 
Figure 4. Size distribution obtained from Dynamic light 
scattering (DLS) (A) and transmission electron microscope 
(TEM) imaging (B) for an aqueous solution of β-annulus-coiled-
coil-B peptide at 50 µM in 10 mM Tris-HCl buffer (pH 7.4) at 
25°C. TEM samples were stained with sodium 
phosphotungstate. (C) Aggregate diameter as a function of 
peptide concentration. (D) Effect of peptide concentrations on 
the scattering intensity obtained from DLS in 10 mM Tris-HCl 
buffer (pH 7.4) at 25°C.
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thioesterification of the peptide with thioester catalysis in 
DMSO, but thioester exchange in the NCL reaction did not 
occur. Thus, the β-annulus-Nbz peptide was converted into β-
annulus-SBn peptide by addition of benzyl mercaptane and 
trimethylamine in DMSO. The obtained crude β-annulus-SBn 
peptide was used for synthesis of β-annulus-coiled-coil-B 
peptide by NCL without purification. The mixture of β-
annulus-SBn peptide and 1.5 equivalent of coiled-coil-B 
peptide was incubated in NCL buffer for 1 h at 37°C. Reverse 
phase HPLC chart of the reaction mixture shows that two peaks 
assigned to β-annulus-SBn peptide at 38 min and coiled-coil B 
peptide at 27 min disappeared and a new peak appeared (Figure 
3A). The new peak was confirmed as β-annulus-coiled-coil B 
peptide by MALDI-TOF-MS (Figure 3B).  
The self-assembly behavior of the β-annulus-coiled-coil-B 
peptide in 10 mM Tris-HCl buffer (pH 7.4) was evaluated by 
dynamic light scattering (DLS) measurement and TEM observation. 
The average diameter obtained from DLS measurement of the 
peptide solution at 100 µM showed formation of assemblies with the 
size of 47 ± 25 nm (Figure 4A), which is comparable to the size of 
artificial viral capsid self-assembled from unmodified β-annulus 
peptide.23 The TEM image of the peptide stained with sodium 
phosphotungstate showed the existence of spherical assemblies of 
30-50 nm (Figure 4B), indicating formation of the artificial viral 
capsid. Figure 4C shows the peptide concentration dependence on 
the size distribution obtained from DLS. Similar assemblies of 
approximately 30–50 nm were formed at the concentration above 10 
µM. In contrast, larger aggregates were observed at the 
concentration below 5 µM. This result might be caused by transient 
formation of large amorphous aggregates, because the dispersion of 
the autocorrelation functions at the concentration below 5 µM were 
large (Figure S1). The peptide concentration dependence on the 
scattering intensity indicates that the critical aggregation 
concentration (CAC) of the peptide in the buffer at 25°C is 5-10 μM. 
The obtained CAC suggests that the artificial viral capsid self-
assembled from the β-annulus-coiled-coil-B peptide is more stable 
than the unmodified β-annulus peptide. This may be due to 
interactions among the coiled-coil-B peptides on the artificial viral 
capsid.  
Formation of coiled-coils on the artificial viral capsid self-
assembled from β-annulus-coiled-coil-B by the addition of 
complementary coiled-coil-A peptide was evaluated by circular 
dichroism (CD) spectrum (Figure 5). The CD spectrum of β-
annulus-coiled-coil-B peptide showed the coexistence of random-
coil and β-structures which is similar to the spectrum of unmodified 
β-annulus peptide. The coiled-coil-A peptide showed random 
coiling. In contrast, the CD spectrum of their mixture showed 
negative peaks at 222 nm and 208 nm which indicate formation 
Figure 6. (A) The concentration dependence of coiled-coil-A 
peptide on the molar ellipticity at 222 nm of mixture of β-
annulus-coiled-coil-B peptide (50 µM) and coiled-coil-A 
peptide. (B) The Job’s plot obtained from the molar ellipticity 
at 222 nm of mixture of β-annulus-coiled-coil-B peptide and 
coiled-coil-A peptide.
Figure 5. CD spectra of (red) coiled-coil-A peptide, (blue) β-
annulus-coiled-coil-B peptide, (green) mixture of coiled-coil-A 
peptide and β-annulus-coiled-coil-B peptide, (black) mixture of 
coiled-coil-A peptide and coiled-coil-B peptide at [coiled-coil-A] 
= 12.5 µM, [coiled-coil-B] = [β-annulus-coiled-coil-B] = 50 µM 
in 10 mM Tris-HCl buffer (pH 7.4) at 25°C. 
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of α-helix coiled-coil. Molar ellipticity of this mixture was 
lower than that of the mixture of coiled-coil-B and coiled-coil-
A at the same concentration, suggesting formation of coiled-
coils only at the coiled-coil-B sequence on the β-annulus-
coiled-coil-B peptide. Green curve in Figure 5 was apparently 
smaller than black curve, because molar ellipticity of the CD 
spectrum was divided by the residue molar concentration. A 
difference spectrum subtracting β-annulus peptide from 4:1 
mixture of β-annulus-coiled-coil-B peptide and coiled-coil-A 
peptide before dividing by the residue molar concentration 
showed the formation of about 80% coiled coil (Figure S3).  
Addition of coiled-coil-A peptide to 50 µM β-annulus-coiled-
coil-B peptide decreased the molar ellipticity at 222 nm until 
the concentration of coiled-coil-A of 50 µM (Figure 6A). In 
contrast, the molar ellipticity at 222 nm increased at coiled-coil-
A concentrations above 50 µM. These results suggest that α-
helix content increased at the concentration of 50 µM and less, 
whereas free coiled-coil-A peptide increased at the 
concentration of coiled-coil-A above 50 µM. The Job’s plot of 
the molar ellipticity at 222 nm of the mixture of β-annulus-
coiled-coil-B peptide and coiled-coil-A peptide indicated that 
the stoichiometric ratio of coiled-coil formation is 1:1 (figure 
6B). Formation of assembly of β-annulus-coiled-coil-B peptide 
in the presence of coiled-coil-A peptide was evaluated using 
Figure 7. (A, B) Size distribution obtained from DLS (A) and TEM imaging (B) of the mixture of β-annulus-coiled-coil-B peptide (50 µM) 
and coiled-coil-A peptide at 12.5 µM in 10 mM Tris-HCl buffer (pH 7.4) at 25°C. (C, D) Size distribution obtained from DLS (C) and TEM 
image (D) of the mixture of β-annulus-coiled-coil-B peptide (50 µM) and coiled-coil-A peptide at 50 µM in 10 mM Tris-HCl buffer (pH 
7.4) at 25°C. TEM samples stained with sodium phosphotungstate. (E) Aggregate diameter as a function of coiled-coil-A peptide 
concentration with β-annulus-coiled-coil-B peptide (50 µM) in 10 mM Tris-HCl buffer (pH 7.4) at 25°C. (F) Illustration of the assembly 
of β-annulus-coiled-coil-B peptide (50 µM) and coiled-coil-A peptide at the concentration of coiled-coil-A at 0 µM (a), 12.5 µM (b), and 
50 µM (c).
ARTICLE Journal Name 
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
DLS measurements and TEM observations. The size 
distribution obtained from DLS of the 4:1 mixture showed 
formation of assemblies with the size of 46 ± 14 nm (Figure 
7A), which is comparable to the size of artificial viral capsid 
self-assembled from β-annulus-coiled-coil-B peptide alone 
(Figure 4A). In the TEM image of the 4:1 mixture, spherical 
assemblies with the size of 60 nm bearing grains of about 5 nm 
on the surface were abundantly observed (Figure 7B). In 
contrast, the TEM image of the 1:1 mixture indicated formation of 
fibrous assemblies with the length of about 1 µm (Figure 7D) which 
is supported by size distribution obtained from DLS measurement 
(Figure 7C). The size distribution of the mixtures is comparable 
to that of the artificial viral capsid at the concentrations of 12.5 
µM and less, whereas larger assemblies formed with a size of 
about 1 µm at concentrations above 25 µM (Figure 7E). These 
results indicate that coiled-coil structures formed on the 
artificial viral capsid at the concentrations of coiled-coil-A of 
12.5 µM and less, whereas fibrous assemblies formed at 
concentrations above 25 µM. The mechanism of fiber 
formation in the 1:1 mixture was examined whether the fiber 
consisted of β-sheet by using Thioflavin T, which is known that 
the fluorescence intensity increase by binding to amyloid fibril 
consisting of β-sheet. The fluorescence intensity of Thioflavin 
T did not increase in 4:1 mixture of β-annulus-coiled-coil-B 
peptide and coiled-coil-A peptide (Figure S4 blue), whereas the 
fluorescence intensity increased in the 1:1 mixture (Figure S4 
green), indicating the formation of β-sheet fiber. It is possible 
that coiled-coils could not form on the artificial viral capsid 
because the C-terminus side of β-annulus-coiled-coil-B peptide 
crowded the artificial viral capsid at coiled-coil-A 
concentrations above 25 µM. Therefore, it is likely that the 1:1 
mixture formed β-sheet fibrous assemblies by disrupting capsid 
structure (Figure 7F). 
Conclusions 
We synthesized a 49-mer β-annulus peptide bearing coiled-coil 
forming peptide at the C-terminus via the native chemical ligation 
method. The peptide self-assembled into an artificial viral capsid 
with the size of approximately 50 nm in Tris-HCl buffer. CD spectra 
showed the formation of coiled-coils with the addition of 
complementary coiled-coil-A peptide to the artificial viral capsid. 
DLS measurements and TEM observations of the mixture indicated 
the formation of an artificial viral capsid with grains on the surface. 
The dimeric coiled-coil structure on the surface of the artificial viral 
capsid is a promising platform to present various functional 
molecules such as receptor proteins to facilitate cellular uptake. 
Experimental 
General 
Reagents were obtained from a commercial source and used 
without further purification. Reversed-phase HPLC was 
performed at ambient temperature with a Simadzu LC-6AD 
liquid chromatograph equipped with a UV/Vis detector (220 
nm, Shimadzu SPD-20A) using GL Science Inertsil ODS-3 
C18 (4.6 × 250 mm and 20 × 250 mm). MALDI-TOF mass 
spectra were obtained on an Autoflex II (Bruker Daltonics) 
spectrometer under the linear/positive mode with α-cyano-4-
hydroxycinnamic acid (α-CHCA) as matrix.  
 
Syntheses of peptides 
Coiled-coil-B peptide: The peptide H-Cys(Trt)-Gly-Gly-Gly-
Lys(Boc)-Ile-Ala-Ala-Leu-Lys(Boc)-Lys(Boc)- Lys(Boc)-Asn(Trt)- 
Ala-Ala--Leu-Lys(Boc)-Gln(Trt)-Lys(Boc)-Ile-Ala-Ala--Leu-
Lys(Boc)-Gln(Trt)-resin was synthesized on Fmoc-NH-SAL Resin 
(Watanabe Chemical Ind. Ltd., 0.21 mmol/g) using Fmoc-based 
coupling reactions (4 equivalent of Fmoc amino acids). Solutions of 
(1-cyano-2-ethoxy-2-oxoethylidenaminooxy) dimethylamino-
morpholino-carbenium hexafluorophosphate (COMU) and 
diisopropylamine in N-methylpyrrolidone (NMP) were used as 
coupling reagents. 20% Piperidine in N,N-dimethylformamide 
(DMF) was used for Fmoc deprotection. Progression of coupling 
reaction and Fmoc deprotection was confirmed by TNBS and 
chloranil test kit (Tokyo Chemical Industry Co., Ltd.). The peptidyl 
resin was washed with NMP. The peptide was deprotected and 
cleaved from the resin by treatment with a mixture of 
TFA:water:1,2-ethanedithiol:triisopropylsilane = 9.5:0.25:0.25:0.1 at 
room temperature for 3 h. The reaction mixture was filtered to 
remove the resin and the filtrate was concentrated under vacuum. 
The peptide was precipitated by adding methyl tert-butyl ether 
(MTBE) to the residue and the supernatant was decanted. After 
repeating the washing with MTBE thrice, the precipitated peptide 
was dried in vacuo. The crude product was purified by reverse-phase 
HPLC (RP-HPLC, Inertsil ODS3 C18) eluting with a linear gradient 
of CH3CN/water containing 0.1% TFA (85/15 to 25/75 over 100 
min). The fraction containing the desired peptide was lyophilized to 
give 7 mg of a flocculent solid (5.9% yield). MALDI-TOF MS 
(matrix: α-CHCA): m/z = 2552 [M]+.  
Coiled-coil-A peptide (EIAALEKENAALEQEIAALEQ): The 
peptide was synthesized by almost the same procedure described 
above. After loading the amino acid, the peptidyl resin was added to 
the mixture of 3 equivalent of acetic anhydride and 4.5 equivalent of 
DIPEA in DMF to protect the amine of N-terminus by acetyl group. 
The isolated yield was 6.8%. MALDI-TOF-MS (matrix : α-CHCA): 
m/z = 2325 [M]+. 
β-Annulus-Nbz peptide: The β-annulus peptide functionalized 
at the C-terminus with an N-acyl-benzimid-azolinone 
(INHVGGTGGAIMAPVAVTRQLVGG-Nbz) was synthesized 
at 0.25 mmol scale on commercially available Dawson Dbz 
AM resin (Novabiochem®, San Diego, CA, USA). The amino 
group of the resin was protected by allyloxycarbonate (Alloc) 
with a mixture of 7 equivalent of Allylchloroformate and 1 
equivalent of DIPEA at room temperature for 24 h. Loading of 
amino acid and deprotection of the Fmoc-group were done by 
almost same procedure described above. After loading of the 
amino acid, deprotection of the Alloc group was used as a 
mixture of 20 equivalent of PhSiH3 and 0.35 equivalent of 
Pd(PPh3)4 in DCM. Then, the resin was treated with 5 
equivalent of p-nitrophenylchloroformate in DCM followed by 
0.5 M DIPEA in DMF to converted Nbz group. The peptide 
was deprotected and cleaved from the resin by treatment with 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
cleavage cocktail for 3 h. The crude yield was 30%. MALDI-
TOF-MS (matrix:α-CHCA): m/z = 2435 [M]+. 
 
Preparation of β-annulus-SBn peptide 
Crude β-annulus-Nbz peptide powder was added to a mixture 
of 10% benzyl mercaptane and 20 mM triethylamine in DMSO 
to convert to benzylthioesterified β-annulus peptide at the C-
terminus. After the solution was incubated at 37°C for 15 min, 
the peptide was precipitated by adding  ethyl acetate to the 
reaction mixture and the supernatant was decanted. After 
repeating the washing with ethyl acetate thrice, the precipitated 
peptide was dried under vacuum. The precipitated peptide was 
used for native chemical ligation without further purification. 
The yield was 66%. MALDI-TOF MS (matrix:α-CHCA): m/z = 
2381 [M]+.  
 
Native Chemical Ligation 
NCL buffer (pH 7.0) was prepared by dissolving 6M 
guanidinium hydrochloride (Gdn•HCl), 20 mM 
triscarboxyethyl phosphine (TCEP), 200 mM 4-
mercaptophenylacetic acid (MPAA), 200 mM sodium 
phosphate in water and degassed with N2. The coiled-coil-B 
peptide bearing cysteine at N-terminus (0.75 µmol) and β-
annulus-SBn peptide (0.5 µmol) were dissolved in NCL buffer 
and the mixture was incubated at 37°C for 1 h. The reaction 
mixture purified by reverse-phase HPLC (Inertsil ODS3 C18) 
eluting with a linear gradient of CH3CN:water containing 0.1% 
TFA (80:20 to 60:40 over 100 min). The isolated yield was 
42.7%. MALDI-TOF MS (matrix:α-CHCA): m/z = 4809[M]+. 
 
Dynamic light scattering (DLS) measurements 
Stock solutions (1.0 mM) of peptide were dissolved in 10 mM Tris-
HCl buffer without sonication or heating. Samples were prepared by 
diluting stock solutions with 10 mM Tris-HCl buffer and were 
incubated at 25°C for 1 h before measurements using a Zetasizer 
NanoZS (Malvern Instruments Ltd.) instrument with incident He-Ne 
laser (633 nm). The correlation time of scattered light intensity G (τ) 
was measured several times and the averaged data were fitted to 
equation (2), where B is a baseline, A is amplitude, q is scattering 
vector, τ is delay time, and D is the diffusion coefficient. 
𝐺𝐺 (𝜏𝜏) =  𝐵𝐵 + 𝐴𝐴 exp(−2𝑞𝑞2𝐷𝐷𝜏𝜏) (2)  
The hydrodynamic radius (RH) of the scattering particles was 
calculated by the Stokes-Einstein equation (eq. 3), where η is solvent 
viscosity, kB is Boltzmann’s constant, and T denotes the absolute 
temperature.  
𝑅𝑅𝐻𝐻 =  𝑘𝑘𝐵𝐵𝑇𝑇6𝜋𝜋𝜋𝜋𝐷𝐷 (3)  
 
Transmission electron microscopy (TEM)  
An aliquot (5 µL) of DLS sample solutions was applied to a 
carbon coat grid (C-SMART Hydrophilic TEM gilds, 
ALLANCE Biosystems), left for 60 s, and removed. A drop of 
2 wt% aqueous sodium phosphotungstate was placed on each of 
the grids. The sample-loaded carbon-coated grids were dried in 
vacuo. The carbon coat grids were subjected to TEM 
observation (JEOL JEM 1400 Plus) with acceleration voltage of 
80 kV.  
 
CD spectra 
CD spectra were recorded at 25°C with a JASCO J-820 
spectrophotometer using a 1-mm quartz cell. A series of 
mixtures containing β-annulus-coiled-coil-B peptide and 
coiled-coil-A peptide were prepared such that the sum of their 
total peptide concentration remained constant (50 µM), and the 
mixtures were incubated for 1 h before measurement. The mole 
fraction of coiled-coil-A peptide was varied from 0 to 1. The 
molar ellipticity at 222 nm was plotted against the molar 
fraction of the coiled-coil-A peptide to estimate the 
stoichiometry. 
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